Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-33.64
Price to sales ratio
1.91

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2565
EVO
Evotec SE - American Depositary Shares each representing 1/2 of
2.43 USD-12.90%-14.44%-13.83%-43.09%864.01 M USD
2576
AMPH
Amphastar Pharmaceuticals, Inc. - Common Stock
19.29 USD+3.04%-3.84%-4.08%-20.88%850.55 M USD
2703
IRWD
Ironwood Pharmaceuticals, Inc. - Class A Common Stock
4.21 USD-5.82%-6.03%+11.67%+468.92%693.02 M USD
2896
TLRY
Tilray Brands, Inc. - Common Stock
4.46 USD+0.90%+0.45%-12.20%+565.67%519.81 M USD

Frequently asked questions about Esperion Therapeutics, Inc. - Common Stock

What is the Esperion Therapeutics, Inc. - Common Stock stock price today?

The current price of Esperion Therapeutics, Inc. - Common Stock (ESPR) is 3.18. Over the past 24 hours, the stock has changed by -0.31%. Follow the ESPR chart for real-time price dynamics.

What is the stock ticker of Esperion Therapeutics, Inc. - Common Stock?

Esperion Therapeutics, Inc. - Common Stock trades under the ticker ESPR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Esperion Therapeutics, Inc. - Common Stock stock going up?

ESPR has changed by +0.63% over the last week, +0.63% over the last month, and +169.49% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Esperion Therapeutics, Inc. - Common Stock net income for the last quarter?

Esperion Therapeutics, Inc. - Common Stock reported net income of -25.2 M for the last quarter. The previous quarter showed 61.83 M, which means net income changed by -140.75%.

How many employees does Esperion Therapeutics, Inc. - Common Stock have?

As of the latest available data, Esperion Therapeutics, Inc. - Common Stock has 294 employees. Workforce size can provide additional context about the company's scale and operations.

What is Esperion Therapeutics, Inc. - Common Stock EBITDA?

Esperion Therapeutics, Inc. - Common Stock EBITDA is -5.96 M, and its EBITDA margin is -7.45%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Esperion Therapeutics, Inc. - Common Stock stock?

You can buy Esperion Therapeutics, Inc. - Common Stock (ESPR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Esperion Therapeutics, Inc. - Common Stock stock?

Investing in Esperion Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ESPR chart and related analysis on metatrader.com as part of your research.

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

News